Skip to main navigation

Corporate Links

  • Our Technology
    • Corporate Presentation
    • Presentations & Publications
  • Pipeline
    • PSA-Associated Cancers
    • HOT Program
    • HER2-Associated Cancers
    • NEO Program
    • HPV-Associated Cancers
    • Patient Stories
  • Partners
  • About Us
  • Investors
White Logo Color Logo

Corporate Links

  • Our Technology
    • Corporate Presentation
    • Presentations & Publications
  • Pipeline
    • PSA-Associated Cancers
    • HOT Program
    • HER2-Associated Cancers
    • NEO Program
    • HPV-Associated Cancers
    • Patient Stories
  • Partners
  • About Us
  • Investors

Advaxis is a clinical-stage biotechnology company

focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins.

In the News
Our Clinical Trials
Corporate Presentation

Home

Corporate Presentation

Corporate Presentation - March 2021

UPLOADED:

March 16, 2021

View PDF

Corporate Presentation - March 2021

In the News

Immunotherapy: A New Strategy for the Treatment of Cervical Cancer: Interview with Dr. Christian Marth and Dr. Sharad Ghamande

Tolerability of ADXS11-001 Lm-LLO Listeria Based Immunotherapy With Mitomycin, Fluorouracil and Radiation for Anal Cancer

Cancer vaccines, long considered failures, are hot again

In the News

STAY TUNED

Mailing List

Sign up for email alerts for Press Releases and Advaxis' breaking news.

SOCIAL

Follow Us

Stay up to date on the latest events, news, and happenings on Advaxis and Immunotherapy.

Corporate Footer Links

    Our Lm Technology™
  • Intellectual Property
  • The Advaxis Difference
  • Corporate Presentation
  • Presentations and Publications
    Pipeline
  • PSA-Associated Cancers
  • HOT Program
  • HER2-Associated Cancers
  • NEO Program
  • HPV-Associated Cancers
  • Patient Stories
    Partners
  • Academic Institutions
  • Clinical Partners
  • Licensing Agreements
    About Us
  • Board of Directors
  • Careers
  • In the News
  • Leadership
  • Our Values
  • Scientific Advisory
    Investors
  • News & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Shareholder Services
  • Videos
Color Logo

Corporate Footer Links

    Our Lm Technology™
  • Intellectual Property
  • The Advaxis Difference
  • Corporate Presentation
  • Presentations and Publications
    Pipeline
  • PSA-Associated Cancers
  • HOT Program
  • HER2-Associated Cancers
  • NEO Program
  • HPV-Associated Cancers
  • Patient Stories
    Partners
  • Academic Institutions
  • Clinical Partners
  • Licensing Agreements
    About Us
  • Board of Directors
  • Careers
  • In the News
  • Leadership
  • Our Values
  • Scientific Advisory
    Investors
  • News & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Shareholder Services
  • Videos
Copyright © 2021 All Rights Reserved
Color Logo